Minaris Advanced Testing delivers comprehensive characterization services for human-derived cell banks to support the safety, traceability, and regulatory compliance of advanced therapy programs. Our risk-based, lifecycle approach spans Master Cell Bank (MCB), Working Cell Bank (WCB), and End-of-Production Cells (EOP), with expanded testing considerations for donor eligibility, human-specific viral panels, genetic stability, tumorigenicity (where applicable), and phenotypic characterization. Backed by decades of biosafety expertise and GMP-compliant laboratories, we provide the robust, regulatory-ready data needed to ensure your human cell substrates are thoroughly qualified and fit for clinical and commercial use.
Download the flyer to explore our recommended testing panel for human-derived cell banks and see how Minaris can support your program from bank establishment through commercialization.
